BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 31842935)

  • 1. HTLV-1 contains a high CG dinucleotide content and is susceptible to the host antiviral protein ZAP.
    Miyazato P; Matsuo M; Tan BJY; Tokunaga M; Katsuya H; Islam S; Ito J; Murakawa Y; Satou Y
    Retrovirology; 2019 Dec; 16(1):38. PubMed ID: 31842935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional and Epigenetic Regulatory Mechanisms Affecting HTLV-1 Provirus.
    Miyazato P; Matsuo M; Katsuya H; Satou Y
    Viruses; 2016 Jun; 8(6):. PubMed ID: 27322309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High IFN-γ/IL-10 expression ratio and increased frequency of persistent human T-cell lymphotropic virus type 1-infected clones are associated with human T-cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis development.
    Espíndola OM; Oliveira LC; Ferreira PM; Leite AC; Lima MA; Andrada-Serpa MJ
    Intervirology; 2015; 58(2):106-14. PubMed ID: 25833232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo proviral burden and viral RNA expression in T cell subsets of patients with human T lymphotropic virus type-1-associated myelopathy/tropical spastic paraparesis.
    Cho I; Sugimoto M; Mita S; Tokunaga M; Imamura F; Ando M
    Am J Trop Med Hyg; 1995 Oct; 53(4):412-8. PubMed ID: 7485696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The retrovirus HTLV-1 inserts an ectopic CTCF-binding site into the human genome.
    Satou Y; Miyazato P; Ishihara K; Yaguchi H; Melamed A; Miura M; Fukuda A; Nosaka K; Watanabe T; Rowan AG; Nakao M; Bangham CR
    Proc Natl Acad Sci U S A; 2016 Mar; 113(11):3054-9. PubMed ID: 26929370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human T cell leukemia virus type I (HTLV-I) molecular genotypes and disease outcome.
    Renjifo B; Chou K; Soto Ramirez L; Garcia Vallejo F; Essex M
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S146-53. PubMed ID: 8797717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of human T-lymphotrophic virus type I in patients with systemic lupus erythematosus.
    Lipka K; Tebbe B; Finckh U; Rolfs A
    Clin Exp Dermatol; 1996 Jan; 21(1):38-42. PubMed ID: 8689767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human T-cell lymphotropic virus type I (HTLV-I) proviral DNA viral load among asymptomatic patients and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Montanheiro PA; Oliveira AC; Posada-Vergara MP; Milagres AC; Tauil C; Marchiori PE; Duarte AJ; Casseb J
    Braz J Med Biol Res; 2005 Nov; 38(11):1643-7. PubMed ID: 16258633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human retroviral antisense mRNAs are retained in the nuclei of infected cells for viral persistence.
    Ma G; Yasunaga JI; Shimura K; Takemoto K; Watanabe M; Amano M; Nakata H; Liu B; Zuo X; Matsuoka M
    Proc Natl Acad Sci U S A; 2021 Apr; 118(17):. PubMed ID: 33875584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Alternatively Spliced Human T-Cell Leukemia Virus Type 1 mRNAs Is Influenced by Mitosis and by a Novel cis-Acting Regulatory Sequence.
    Cavallari I; Rende F; Bona MK; Sztuba-Solinska J; Silic-Benussi M; Tognon M; LeGrice SF; Franchini G; D'Agostino DM; Ciminale V
    J Virol; 2016 Feb; 90(3):1486-98. PubMed ID: 26581997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CG dinucleotide suppression enables antiviral defence targeting non-self RNA.
    Takata MA; Gonçalves-Carneiro D; Zang TM; Soll SJ; York A; Blanco-Melo D; Bieniasz PD
    Nature; 2017 Oct; 550(7674):124-127. PubMed ID: 28953888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of Expression and Latency in BLV and HTLV.
    Pluta A; Jaworski JP; Douville RN
    Viruses; 2020 Sep; 12(10):. PubMed ID: 32992917
    [No Abstract]   [Full Text] [Related]  

  • 13. Phylogenetic classification of human T cell leukaemia/lymphoma virus type I genotypes in five major molecular and geographical subtypes.
    Vidal AU; Gessain A; Yoshida M; Tekaia F; Garin B; Guillemain B; Schulz T; Farid R; De Thé G
    J Gen Virol; 1994 Dec; 75 ( Pt 12)():3655-66. PubMed ID: 7996161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimeric matrix proteins encoded by defective proviruses with large internal deletions in human T-cell leukemia virus type 1-infected humans.
    Morozov VA; Lagaye S; Taylor GP; Matutes E; Weiss RA
    J Virol; 2000 May; 74(9):3933-40. PubMed ID: 10756004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep Sequencing Analysis of Human T Cell Lymphotropic Virus Type 1 Long Terminal Repeat 5' Region from Patients with Tropical Spastic Paraparesis/Human T Cell Lymphotropic Virus Type 1-Associated Myelopathy and Asymptomatic Carriers.
    Rego FF; de Oliveira T; Giovanetti M; Galvão-Castro B; Gonçalves Mde S; Alcantara LC
    AIDS Res Hum Retroviruses; 2016 Mar; 32(3):279-83. PubMed ID: 26472535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of host restriction factors and the HTLV-1 subtype on susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Nozuma S; Matsuura E; Kodama D; Tashiro Y; Matsuzaki T; Kubota R; Izumo S; Takashima H
    Retrovirology; 2017 Apr; 14(1):26. PubMed ID: 28420387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HTLV-1 intragenic viral enhancer influences immortalization phenotype
    Maksimova V; Smith S; Seth J; Phelps C; Niewiesk S; Satou Y; Green PL; Panfil AR
    Front Immunol; 2022; 13():954077. PubMed ID: 35958554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of HLA class I and class II expression in human T-lymphotropic virus type I-infected neuroblastoma cells.
    Lehky TJ; Cowan EP; Lampson LA; Jacobson S
    J Virol; 1994 Mar; 68(3):1854-63. PubMed ID: 7906313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fucoidan therapy decreases the proviral load in patients with human T-lymphotropic virus type-1-associated neurological disease.
    Araya N; Takahashi K; Sato T; Nakamura T; Sawa C; Hasegawa D; Ando H; Aratani S; Yagishita N; Fujii R; Oka H; Nishioka K; Nakajima T; Mori N; Yamano Y
    Antivir Ther; 2011; 16(1):89-98. PubMed ID: 21311112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p30 protein: a critical regulator of HTLV-1 viral latency and host immunity.
    Moles R; Sarkis S; Galli V; Omsland M; Purcell DFJ; Yurick D; Khoury G; Pise-Masison CA; Franchini G
    Retrovirology; 2019 Dec; 16(1):42. PubMed ID: 31852501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.